Low Libido Treatment
Low libido in women is a recognized medical condition with effective treatments. FDA-approved flibanserin and evidence-based options prescribed online. Private, same-day consultation.
Prescription required. Provider determines if clinically appropriate.
Low libido treatment for women online
Hypoactive sexual desire disorder (HSDD) is one of the most common female sexual concerns and has multiple contributing factors — hormonal changes, depression, stress, certain medications (SSRIs particularly), and relationship dynamics. FDA-approved flibanserin and evidence-based off-label options exist. The FirstCall platform connects you with an independent, board-certified physician for evaluation and, when clinically appropriate, a prescription sent to a pharmacy of your choice.
hormonal changes, SSRIs, stress, relationship factors, depression
flibanserin (Addyi®)
low-dose testosterone (for postmenopausal women), bupropion
Educational content. Last clinically reviewed by the FirstCall Clinical Editorial Board, June 2026. The FirstCall platform provides access to independent, licensed physicians; final clinical decisions rest with the prescribing physician.
Understanding low libido in women — causes and treatment
Understanding the condition makes the treatment decision clearer.
Low libido — clinically termed hypoactive sexual desire disorder (HSDD) — is defined as persistently low sexual desire that causes personal distress. It is the most common female sexual complaint. Contributing factors include hormonal changes (perimenopause, postpartum, thyroid dysfunction), relationship factors, depression, stress, certain medications (especially SSRIs), and physical conditions. Often multiple factors contribute simultaneously. Identifying the primary driver allows for targeted, effective treatment.
Key insight: HSDD is a recognized medical diagnosis — not a personal failing or relationship problem. Effective FDA-approved and evidence-based treatments exist. A private 10-minute consultation is the first step.
Low libido is a medical condition — not something to just accept
Hypoactive sexual desire disorder affects approximately one in three women. It causes real distress and real relationship strain — documented in peer-reviewed clinical research. Yet the vast majority of women who experience it never discuss it with a physician. The barrier is embarrassment, not access. A FirstCall consultation is completely private, takes 10 minutes, and results in a same-day prescription if clinically appropriate.
What to expect
Set realistic expectations and stay consistent — results take time.
Flibanserin or hormonal therapy initiated. Initial adjustment period as treatment takes effect.
Many women notice increased desire within the first month. Effects build with consistent use.
Consistent improvement in sexual desire and satisfaction typically reported at 2–3 months.
Continued treatment maintains improvement. Dose adjustments available as needed.
Treating HSDD changes relationships — documented in clinical research
The impact of low libido on intimate relationships is well-documented — reduced sexual satisfaction for both partners, increased relationship stress, avoidance of intimacy, and reduced personal confidence. Clinical studies of HSDD treatment consistently show improvements not only in sexual desire but in relationship satisfaction and overall quality of life. This is worth treating.
The science behind low libido treatment
Evidence-based treatment addresses the underlying mechanism — not just the symptoms.
The first FDA-approved medication specifically for hypoactive sexual desire disorder in premenopausal women. Works on brain dopamine and serotonin receptors to increase sexual desire. Taken daily at bedtime. Not a hormonal treatment. Effects build over weeks — not immediate. Requires a prescription.
Used off-label for HSDD with substantial clinical evidence, particularly in postmenopausal women. Low-dose testosterone addresses hormonal deficiency that can contribute to reduced desire. Your physician will assess hormone levels and health history before recommending this approach.
In perimenopausal and menopausal women, declining estrogen contributes significantly to reduced sexual desire and comfort. Hormone replacement therapy addressing this decline can restore desire as part of broader menopausal symptom management. Often combined with local vaginal estrogen for comfort.
Treatments that work together
Comprehensive care often combines complementary treatments for better outcomes.
The most private consultation you will ever have.
Sexual health concerns are among the most private. FirstCall removes every barrier to care. Your consultation is online, completely confidential, and HIPAA-protected. Medication ships in plain, unmarked packaging — no brand name visible. No waiting room, no in-person visit, no conversation with anyone you know.
How it works
From first visit to prescription in as little as 15 minutes.
Brief online health questionnaire from your phone. Takes 5–10 minutes.
A board-certified physician reviews privately and recommends your treatment — same day.
Sent to your pharmacy or shipped discreetly in plain, unmarked packaging.
Low libido treatment — affordable pricing
Free consultation. FDA-approved and evidence-based options.
How we’re different
FirstCall was built to make women’s health care genuinely accessible.
No 3-week appointment waitlists. Board-certified physicians prescribe the same day — often within the hour.
HIPAA-protected. Plain unmarked packaging. No waiting room, no front desk, no one who knows you.
One membership covers your whole household — women’s, men’s, senior care, and pets.
Trusted telehealth provider since 2017. Board-certified physicians licensed in your state.
*Based on publicly available competitor information.
Frequently asked questions
Clear answers about low libido treatment and how FirstCall works.
Flibanserin carries a black box warning: do not drink alcohol within 2 hours of taking flibanserin — this combination can cause severe low blood pressure and fainting. Do not take with strong CYP3A4 inhibitors. Low-dose testosterone in women requires monitoring for androgenic side effects including acne and hair changes. Discuss all current medications and supplements with your physician before starting treatment. Read full prescribing information ›
Related treatments
Other women’s health treatments available through FirstCall.
